1117 related articles for article (PubMed ID: 18301300)
21. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
[TBL] [Abstract][Full Text] [Related]
22. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
[TBL] [Abstract][Full Text] [Related]
23. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.
Raut CP; Izzo F; Marra P; Ellis LM; Vauthey JN; Cremona F; Vallone P; Mastro A; Fornage BD; Curley SA
Ann Surg Oncol; 2005 Aug; 12(8):616-28. PubMed ID: 15965731
[TBL] [Abstract][Full Text] [Related]
24. Radiofrequency ablation for unresectable tumors of the liver.
Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
[TBL] [Abstract][Full Text] [Related]
25. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
[TBL] [Abstract][Full Text] [Related]
27. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
[TBL] [Abstract][Full Text] [Related]
28. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
[TBL] [Abstract][Full Text] [Related]
29. [Standard treatment of liver malignancies with radiofrequency ablation].
Chen MH; Yang W; Yan K; Gao W; Dai Y; Wang YB; Huo L; Zhang H; Huang XF
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1741-6. PubMed ID: 16253159
[TBL] [Abstract][Full Text] [Related]
30. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma.
Imamura J; Tateishi R; Shiina S; Goto E; Sato T; Ohki T; Masuzaki R; Goto T; Yoshida H; Kanai F; Hamamura K; Obi S; Yoshida H; Omata M
Am J Gastroenterol; 2008 Dec; 103(12):3057-62. PubMed ID: 19086957
[TBL] [Abstract][Full Text] [Related]
31. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
Vallone P; Catalano O; Izzo F; Siani A
Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.
Yamasaki T; Kurokawa F; Shirahashi H; Kusano N; Hironaka K; Okita K
Cancer; 2002 Dec; 95(11):2353-60. PubMed ID: 12436442
[TBL] [Abstract][Full Text] [Related]
33. [Radiofrequency ablation for hepatocellular carcinoma and liver metastases].
Yasumoto T; Murakami T; Katsumoto Y; Hashimoto T; Noda S; Murata K; Kinuta M; Nakamura H
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1596-9. PubMed ID: 16315881
[TBL] [Abstract][Full Text] [Related]
34. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
[TBL] [Abstract][Full Text] [Related]
35. Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response.
Guglielmi A; Ruzzenente A; Pachera S; Valdegamberi A; Sandri M; D'Onofrio M; Iacono C
Am J Gastroenterol; 2008 Mar; 103(3):597-604. PubMed ID: 17970836
[TBL] [Abstract][Full Text] [Related]
36. Surgical radiofrequency ablation for treatment of hepatocellular carcinoma: an endoscopic or open approach.
Tanaka S; Shimada M; Shirabe K; Taketomi A; Maehara S; Tsujita E; Ito S; Kitagawa D; Maehara Y
Hepatogastroenterology; 2009; 56(93):1169-73. PubMed ID: 19760963
[TBL] [Abstract][Full Text] [Related]
37. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
Glaiberman CB; Pilgram TK; Brown DB
J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
[TBL] [Abstract][Full Text] [Related]
38. [Experience of radiofrequency ablation therapy for hepatocellular carcinoma].
Iwauchi T; Yamada N; Amano R; Ohira M; Nishino H; Hirakawa K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1663-5. PubMed ID: 16315902
[TBL] [Abstract][Full Text] [Related]
39. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma.
Khan MR; Poon RT; Ng KK; Chan AC; Yuen J; Tung H; Tsang J; Fan ST
Arch Surg; 2007 Dec; 142(12):1136-43; discussion 1143. PubMed ID: 18086979
[TBL] [Abstract][Full Text] [Related]
40. Preliminary assessment of utility of radiofrequency ablation technique in treatment of primary hepatocellular carcinoma (HCC) in patients with hepatic cirrhosis.
Witczak-Malinowska K; Zadrozny D; Studniarek M; Szurowska E; Michalska Z; Stalke P; Sikorska K; Lakomy EA
Med Sci Monit; 2003 Aug; 9 Suppl 3():68-72. PubMed ID: 15156617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
